Clinical Trial Update: The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating simvastatin's effect on the epithelial-mesenchymal transition in triple-negative breast cancer. Recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Indonesia University | Conditions: Triple Negative Breast Cancer, Chemotherapy Effect | Phase 2 | Status: RECRUITING